Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
PMH5 A DISCRETE EVENTS MODEL OF LONG-TERM OUTCOMES AND COST OF TREATMENT WITH LONG ACTING RISPERIDONE IN SCHIZOPHRENIA
PCV27 COST-EFFECTIVENESS ANALYSIS OF ANTITHROMBOTIC TREATMENT WITH CLOPIDOGREL IN PATIENTS WITH MYOCARDIAL INFARCTION, STROKE, AND PERIPHERAL ARTERIAL DISEASE IN THE NETHERLANDS
Case-mix methodology for the NHS outcomes framework GP Patient Survey Questionnaire Data
The objective of the research described in the current report was to explore alternative methodologies which could be used to determine whether the health status of people living with long- term… Expand
1146 POSTER Cost-effectiveness of zoledronic acid in the prevention of fractures in postmenopausal women with early breast cancer receiving aromatase inhibitor: Application to the United Kingdom
Whom and how to treat: weighing the costs and effects.
- B. V. Hout
Taking the right decision in health care may be as much an art as a science. However, without exception and whatever the decision, usage is made of scarce resources and they may be used in an… Expand
PMH10 COSTS AND EFFECTS OF RISPERDAL CONSTATM IN COMPARISON TO CONVENTIONAL DEPOT AND SHORT-ACTING ATYPICAL FORMULATIONS IN GERMANY
PCV63 COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL IN ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION IN THE NETHERLANDS
IN4 Health Care Resource Utilization (HCRU) and Costs among Patients Treated for Nosocomial Pneumonia (NP) Caused by Methicillin Resistant Staphylococcus Aureus (Mrsa): Secondary Analysis of a…
Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in post-menopausal women with early-stage breast cancer receiving aromatase inhibitors in the United Kingdom